Table 1 Potential blood biomarkers for cerebral malaria caused by P. falciparum and P. coatneyi infections
From: Methylene blue treatment of fatal cerebral malaria and identification of potential blood biomarkers
Biomarkers | Association with | Description and Function in Malaria | References | |
|---|---|---|---|---|
Neutrophils | CM | |||
S100A9 | + | + | Leukocyte extravasation and inflammatory responses; increased S100A9 plasma level was found to be correlated with the parasite load and periodic fever. | |
MAG | - | + | Plays an important role in axons and myelin interactions, which can be damaged by infected RBC sequestration in CM. | |
IL1RN | + | + | Involved in anti-inflammatory activities; upregulated in plasma and PBMC of CM patients. | |
S100A8 | + | + | Leukocyte extravasation and inflammatory responses; increased S100A8 plasma level was found to be correlated with the parasite load and periodic fever. | |
CD177 | + | + | Surface glycoprotein that plays a role in neutrophil activation and regulates neutrophils transendothelial migration; upregulated in CM patients. | |
LCN2 | + | + | Iron sequestration in SMA; increased LCN2 plasma level in CM patients. | |
MMP9 | + | + | Breakdown BBB for neutrophil transmigration; upregulated in whole blood of CM children. | |
NFE2 | + | - | Regulates the phenotypic polarization of neutrophils. Important transcription factor in erythropoiesis, downregulated in P. vivax infection | |
CHIT1 | + | + | A resistant candidate gene of severe malaria; increased CHIT1 plasma level in African CM children; diversity of plasma CHIT1 activity affected by genetic and environmental factors. | |